• Actinomycin D (A4448): Scenario-Based Solutions for Reliable

  2026-05-09

  This authoritative, scenario-driven article addresses real-world laboratory challenges in RNA stability, apoptosis, and transcription inhibition assays. By integrating literature evidence and practical expertise, we demonstrate how Actinomycin D (SKU A4448) delivers quantitative reliability, protocol flexibility, and data reproducibility for biomedical researchers.

• HOXC8 Suppresses Pyroptosis in NSCLC by Inhibiting Caspase-1

  2026-05-08

  This study reveals that HOXC8 acts as a transcriptional repressor of caspase-1, thereby preventing pyroptotic cell death and promoting non-small cell lung carcinoma (NSCLC) survival. These findings highlight the interplay between epigenetic transcriptional control and inflammasome-mediated cell death, offering new insights for inflammation and cancer research.

• Troglitazone as a PPARγ Agonist: Advanced Workflows & TAM Mo

  2026-05-08

  Troglitazone’s unique dual action as a PPARγ/α agonist enables researchers to dissect both metabolic and tumor immune microenvironments in a single experimental system. This article delivers protocol enhancements, troubleshooting strategies, and practical insights for leveraging troglitazone in studies on type 2 diabetes and tumor-associated macrophages, with an emphasis on SPP1-driven pathways.

• LNP-Delivered B7H3×CD3 BiTE mRNA: Advancing Tumor Immunother

  2026-05-07

  This article examines a recent study that demonstrates the potent antitumor effects of lipid nanoparticle (LNP)-delivered mRNA encoding a B7H3-redirected bispecific antibody (BiTE). By achieving efficient mRNA delivery and extending therapeutic protein expression, the study offers significant advances for mRNA-based cancer immunotherapy approaches.

• COX Inhibitors Suppress Canine Mammary Tumor Cells In Vitro

  2026-05-07

  This study demonstrates that the NSAIDs piroxicam and deracoxib, both individually and in combination, significantly inhibit proliferation and induce apoptosis in a canine mammary carcinoma cell line. The findings highlight the potential of COX inhibitors as adjunctive antitumor agents and provide mechanistic insights for future research on neoplastic therapies.

• GKT137831: Dual NADPH Oxidase Nox1/Nox4 Inhibitor in Oxidati

  2026-05-06

  GKT137831 empowers researchers to dissect oxidative stress mechanisms with high selectivity, enabling robust modeling of vascular and fibrotic disease processes. This article delivers evidence-backed workflows, advanced troubleshooting, and actionable protocol enhancements to maximize reproducibility and translational impact.

• Nystatin (Fungicidin): Advanced Antifungal Workflows & Innov

  2026-05-06

  Nystatin (Fungicidin) from APExBIO delivers robust, quantifiable inhibition of Candida and Aspergillus species, enabling researchers to dissect membrane disruption and resistance mechanisms with workflow-ready protocols. Recent synergy findings with moxidectin unlock new assay design frontiers and antifungal potentiation strategies.

• JHU-083: Applied Protocols for Glutaminase Pathway Research

  2026-05-05

  JHU-083, a potent 6-diazo-5-oxo-L-norleucine precursor, empowers selective glutaminase inhibition in neurological and cerebral malaria models. This article delivers hands-on protocols, troubleshooting insights, and bridges oxidative stress research with glutaminase pathway modulation for advanced disease modeling.

• Rifampin in Bacterial Resistance Research: Protocols & Troub

  2026-05-05

  Rifampin, a gold-standard rifamycin antibiotic, enables precise transcription inhibition for bacterial resistance mechanism research and synthetic biology. This article covers robust experimental workflows, protocol enhancements, and troubleshooting—bridging foundational mechanism with actionable, real-world assay optimization.

• WNT5a/GSK3/β-catenin Axis Regulates FAP Adipogenesis in Musc

  2026-05-04

  The referenced study identifies the WNT5a/GSK3/β-catenin signaling pathway as a crucial regulatory axis for adipogenic differentiation of skeletal muscle fibro/adipogenic progenitors (FAPs). This work highlights molecular targets that may be leveraged to restrict fat infiltration in muscle disorders, advancing both our mechanistic understanding and therapeutic prospects.

• Z-DEVD-FMK (SKU A1920): Reliable Caspase-3 Inhibitor Insight

  2026-05-04

  This article provides scenario-driven, evidence-based guidance for biomedical researchers using Z-DEVD-FMK (SKU A1920) to resolve common challenges in apoptosis, neuroprotection, and cell viability assays. It demonstrates how Z-DEVD-FMK’s validated protocol parameters, broad caspase and calpain inhibition, and supplier reliability ensure reproducible and interpretable results across advanced cell death studies.

• PCMT1 Drives Ovarian Cancer Metastasis: Insights from CRISPR

  2026-05-03

  Zhang et al. used a genome-wide CRISPR/Cas9 knockout screen to identify PCMT1 as a critical mediator of anoikis resistance and metastasis in ovarian cancer. Their work uncovers the molecular mechanism by which PCMT1 supports metastatic progression via interaction with the extracellular matrix and integrin signaling, highlighting its potential as a therapeutic target.

• Genome-wide CRISPR Screen Links PCMT1 to Ovarian Cancer Meta

  2026-05-02

  Zhang et al. employed a genome-wide CRISPR/Cas9 screen to pinpoint PCMT1 as a key regulator of anoikis resistance and metastatic behavior in ovarian cancer. Their integrative approach reveals molecular mechanisms behind tumor dissemination and underscores PCMT1 as a promising target for future therapeutic development.

• LC–MS/MS Analysis of GS-441524 Prodrug Conversion Pathways

  2026-05-01

  This study presents a novel GS-441524 prodrug (NGP-1) with enhanced lipophilicity and oral bioavailability for SARS-CoV-2 antiviral research. Using an advanced LC–MS/MS method, the authors map in vitro and in vivo conversion pathways, providing actionable insights for nucleoside analog development and pharmacokinetic assessment.

• Hemagglutinin mRNA Vaccine Protects Dairy Cows from H5N1 Cha

  2026-05-01

  This study demonstrates the efficacy of a hemagglutinin-based mRNA–lipid nanoparticle vaccine in protecting lactating dairy cows from a high-dose H5N1 influenza virus challenge. Robust, durable immunity was achieved without compromising animal health or milk production, highlighting the translational potential of mRNA vaccination strategies in livestock.

16001 records 1/1067 page Next 12345 下5页 Last page